Sutro Biopharma, Inc.
STRO
$20.48
-$0.83-3.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.88% | -18.64% | -55.37% | -56.83% | -51.85% |
| Total Receivables | -27.53% | -7.95% | -53.84% | -41.07% | 15.09% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -70.25% | -78.17% | -68.98% | -2.51% | 75.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -24.17% | -23.12% | -56.04% | -55.12% | -47.77% |
|
|
|||||
| Total Current Assets | -24.17% | -23.12% | -56.04% | -55.12% | -47.77% |
| Net Property, Plant & Equipment | -43.58% | -42.35% | -39.91% | -29.82% | -24.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 119.27% | 106.36% | -83.15% | -89.31% | -84.40% |
| Total Assets | -25.88% | -24.72% | -55.11% | -53.60% | -46.35% |
|
|
|||||
| Total Accounts Payable | -22.10% | -32.95% | -27.78% | 13.16% | -29.21% |
| Total Accrued Expenses | -55.54% | -2.68% | -15.99% | -23.18% | 26.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.34% | -2.12% | 4.05% | 10.51% | 16.21% |
| Total Finance Division Other Current Liabilities | 72.94% | -70.31% | -64.68% | -67.43% | -84.57% |
| Total Other Current Liabilities | 72.94% | -70.31% | -64.68% | -67.43% | -84.57% |
| Total Current Liabilities | -28.75% | -46.78% | -43.03% | -45.24% | -42.88% |
|
|
|||||
| Total Current Liabilities | -28.75% | -46.78% | -43.03% | -45.24% | -42.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -64.26% | -55.75% | -49.66% | -45.07% | -41.12% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.37% | 15.69% | 14.47% | 12.35% | 11.42% |
| Total Liabilities | 1.13% | -11.05% | -10.60% | -12.83% | -12.59% |
|
|
|||||
| Common Stock & APIC | 13.00% | 13.45% | 1.69% | 2.22% | 2.97% |
| Retained Earnings | -20.66% | -17.80% | -24.28% | -30.34% | -31.35% |
| Treasury Stock & Other | -346.15% | -1,022.22% | -51.28% | -68.87% | 92.02% |
| Total Common Equity | -221.75% | -159.14% | -396.97% | -178.46% | -121.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -221.75% | -159.14% | -396.97% | -178.46% | -121.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -221.75% | -159.14% | -396.97% | -178.46% | -121.10% |
|
|
|||||